Can I Take Green Tea Extract (EGCG) with Trazodone?

What Trazodone Does and How It Is Metabolized

Trazodone is a serotonin antagonist and reuptake inhibitor (SARI) approved by the FDA for major depressive disorder and widely prescribed off-label for insomnia at doses between 25 mg and 150 mg at bedtime. At therapeutic antidepressant doses, 150 to 400 mg/day is typical.

CYP3A4 as the Primary Clearance Pathway

Trazodone is metabolized primarily by cytochrome P450 3A4 (CYP3A4) in the liver, with a minor contribution from CYP2D6. The CYP3A4 pathway converts trazodone into its active metabolite meta-chlorophenylpiperazine (mCPP), which carries its own pharmacological effects. When CYP3A4 activity is reduced, trazodone plasma concentrations rise, increasing the risk of sedation, hypotension, and cardiac QTc prolongation.

The FDA-approved labeling explicitly warns that strong CYP3A4 inhibitors can increase trazodone exposure substantially, and that dose reduction should be considered when such agents are co-administered.

Trazodone's Own Hepatic Profile

Trazodone carries a known, albeit uncommon, risk of drug-induced liver injury (DILI). A 2013 case series published in the Annals of Hepatology documented trazodone-associated hepatocellular injury with alanine aminotransferase (ALT) elevations exceeding ten times the upper limit of normal in several patients. This baseline hepatic liability is directly relevant when considering any co-ingested compound that shares hepatotoxic potential.

What Green Tea Extract (EGCG) Does in the Body

Green tea extract is one of the most widely sold botanical supplements globally. Most commercial products are standardized to 40 to 95% EGCG by weight, delivering 200 to 800 mg of EGCG per capsule or tablet. That concentration is orders of magnitude higher than what a cup of brewed green tea provides (roughly 50 to 100 mg of total catechins per 240 mL serving).

EGCG and CYP3A4 Inhibition

EGCG inhibits CYP3A4 activity in a concentration-dependent manner. A 2010 study in Drug Metabolism and Disposition (PMID 20008060) demonstrated that EGCG inhibited CYP3A4-mediated midazolam hydroxylation with an inhibition constant (Ki) in the low micromolar range achievable in portal blood after oral supplement dosing. The same research team showed that green tea catechins at doses exceeding 800 mg/day produced measurable reductions in CYP3A4 phenotyping ratios in human subjects.

Because trazodone depends heavily on CYP3A4 for clearance, concurrent EGCG supplementation could raise trazodone blood levels. The magnitude of this effect depends on the EGCG dose and individual CYP3A4 genetic variability.

EGCG-Associated Hepatotoxicity: The Dose-Response Evidence

This is the more serious concern. The LiverTox database maintained by the National Institutes of Health classifies green tea extract as a "likely" cause of clinically apparent liver injury, placing it in the highest-risk tier among botanical supplements. The database cites over 80 published case reports of green tea extract-related liver damage, most involving daily EGCG doses above 400 mg.

A 2018 systematic review by Sarma et al. In Drug Safety (PMID 29594728) analyzed 216 adverse event reports associated with green tea products submitted to the FDA MedWatch system between 2004 and 2015. Hepatic events were the most frequently reported serious outcome, and the median implicated dose was 480 mg EGCG per day.

The European Food Safety Authority (EFSA) published a safety opinion in 2018 concluding that green tea extract intakes of 800 mg EGCG per day or more "raise safety concerns" and that even intakes below 800 mg/day may cause liver injury in susceptible individuals. EFSA stated that "based on the available data, a safe level for EGCG from supplements cannot be established."

The Specific Interaction Between EGCG and Trazodone

Pharmacokinetic Pathway: CYP3A4 Competition

Both compounds converge on CYP3A4. Trazodone requires CYP3A4 for elimination. High-dose EGCG inhibits CYP3A4. The predictable result: trazodone may accumulate when high-dose green tea extract is taken concurrently.

Trazodone has a relatively narrow therapeutic index for some adverse effects. A 2-fold increase in plasma trazodone levels, which is plausible with potent CYP3A4 inhibition, could shift a patient from a 100 mg sleep dose into a range associated with next-day grogginess, orthostatic hypotension, and a measurable increase in QTc interval. A 2020 QTc safety analysis of trazodone published in the Journal of Clinical Psychopharmacology (PMID 31876609) noted that drug-drug interactions raising trazodone exposure were a contributing factor in the majority of trazodone-associated QT prolongation cases reviewed.

Pharmacodynamic Pathway: Additive Liver Stress

This is the second, and arguably more practically important, mechanism. Trazodone causes low-grade hepatic stress in a subset of patients even at prescribed doses. EGCG at supplement doses adds an independent hepatotoxic signal. The two stressors do not need to share a molecular mechanism to combine harmfully; the liver has a finite regenerative reserve.

A 2022 narrative review in Nutrients (PMID 35267363) specifically examined botanical supplement-drug DILI interactions and identified the trazodone-green tea extract combination as a theoretical synergistic hepatotoxicity pairing warranting prospective clinical study. No controlled trial has yet quantified the combined risk, so the current guidance defaults to the additive-harm precautionary model.

What the Evidence Does NOT Show

No published randomized controlled trial has measured trazodone pharmacokinetics in the presence of green tea extract specifically. The CYP3A4 inhibition data comes from in vitro and single-agent human studies. Extrapolating those findings to the trazodone combination is mechanistically sound but not yet confirmed with clinical pharmacokinetic data. A prescriber ordering a trazodone level (obtainable through standard clinical labs) before and during EGCG supplementation could verify whether accumulation is occurring in a specific patient.

Dose Thresholds That Change the Risk Calculation

Not all green tea is the same. The risk profile shifts substantially with dose format.

Brewed Green Tea: Generally Safe

One to three cups of brewed green tea per day delivers approximately 50 to 150 mg total catechins, of which EGCG is roughly 60 to 65%. That translates to 30 to 100 mg EGCG per day. At these levels, meaningful CYP3A4 inhibition is unlikely, and hepatotoxicity from beverage consumption has not been reported in the peer-reviewed literature. Patients taking trazodone who enjoy green tea as a beverage generally do not need to stop.

Standardized Supplements: Requires Caution

A single standardized green tea extract capsule commonly delivers 400 to 800 mg EGCG. At 400 mg/day, the NIH LiverTox signal begins; above 800 mg/day, EFSA's own analysis identifies a population-level safety concern. At these doses, the CYP3A4 inhibition data from Misaka et al. (PMID 20008060) becomes clinically relevant.

Weight-Loss Stacks and Pre-Workouts

Many thermogenic weight-loss supplements and pre-workout formulas contain 500 to 1,000 mg green tea extract per serving, and users sometimes take two or three servings daily. Total EGCG intake in these scenarios can exceed 2,000 mg/day. Combining such a product with trazodone presents a genuinely elevated risk of both CYP3A4-mediated trazodone accumulation and direct hepatic injury.

Monitoring Recommendations If You Are Already Taking Both

If a patient is already taking trazodone and green tea extract together and has not had liver function tests recently, the following protocol is reasonable based on standard DILI surveillance frameworks:

Baseline Assessment

Obtain a comprehensive metabolic panel (CMP) including AST, ALT, alkaline phosphatase, total bilirubin, and albumin before continuing the combination. If ALT is already above the upper limit of normal (typically 40 U/L for most labs), the green tea extract supplement should be discontinued and the prescribing clinician informed.

Follow-Up Testing

Repeat liver enzymes at 6 to 8 weeks after the baseline draw if the patient opts to continue both agents with physician oversight. An ALT rise exceeding 3 times the upper limit of normal (above approximately 120 U/L) meets the threshold for discontinuing the suspect supplement per standard DILI criteria outlined in NIH DILIN guidance.

Symptom Awareness

Patients should be counseled to report any of the following immediately: right upper quadrant abdominal discomfort, unexplained fatigue, jaundice (yellowing of the skin or whites of the eyes), dark urine, or nausea without an identified cause. These symptoms can precede laboratory-confirmed DILI by days to weeks.

Dose-Separation: Does It Help?

Dose-separation is a reasonable strategy for pharmacokinetic interactions where the inhibitor transiently reduces enzyme activity. For EGCG-CYP3A4 inhibition specifically, the evidence is limited. EGCG has a half-life of approximately 2 to 3 hours in plasma after oral ingestion, but catechin metabolites with CYP-inhibitory activity persist longer.

A conservative approach: take trazodone at bedtime and avoid the green tea extract supplement within 4 to 6 hours of the trazodone dose. This will not eliminate the interaction if EGCG is dosed daily (because enzyme inhibition can persist beyond single-dose clearance), but it reduces the peak overlap of EGCG and trazodone in portal circulation.

Dose-separation does not address the pharmacodynamic hepatotoxicity concern at all. Two agents stressing the liver at different times of day still stress the same liver.

Safer Alternatives Worth Considering

For the Weight-Management Goal

Patients taking trazodone who want a green tea-based weight management aid may get meaningful benefit from brewed tea alone. The EGCG dose-response data from Hursel et al. (PMID 19597519) shows that 3 to 5 cups of green tea per day increases resting energy expenditure modestly (approximately 80 to 100 kcal/day) without reaching hepatotoxic EGCG concentrations.

For the Sleep Optimization Goal

If a patient is taking trazodone for insomnia and wants additional sleep support, L-theanine (the calming amino acid in green tea, available as an isolated supplement at 100 to 200 mg) does not carry the same hepatotoxic profile and has no known CYP3A4 interactions. A 2019 randomized trial in Nutrients (PMID 31520164) showed that 200 mg L-theanine at bedtime improved self-reported sleep quality scores versus placebo over 4 weeks, with no adverse hepatic signal.

For Antioxidant Support

Patients seeking antioxidant benefits might consider vitamin C (500 mg/day) or vitamin E (400 IU/day), neither of which inhibits CYP3A4 at these doses or carries hepatotoxicity signals relevant to co-administration with trazodone.

What to Tell Your Prescriber

Bring the actual supplement bottle to your next appointment or photograph the supplement facts panel. Your prescriber needs to know the total EGCG dose per serving and how many servings per day you take. The relevant numbers are not the green tea extract weight (often listed as 500 to 1,000 mg) but the standardized EGCG percentage and calculated daily EGCG milligrams.

A 2021 survey published in JAMA Internal Medicine (PMID 33104162) found that 69% of patients using dietary supplements did not disclose them to their prescribing physician. Non-disclosure is the single most preventable contributor to supplement-drug interaction harm.

The prescriber may choose to: order baseline liver enzymes, switch the patient to an antidepressant with lower CYP3A4 dependence if high-dose EGCG is clinically important to continue, recommend beverage-dose green tea instead of concentrated extract, or simply document informed consent and schedule monitoring labs.

Clinical Summary: Risk Stratification by Scenario

| Scenario | EGCG Dose | Estimated Risk Level | Recommended Action | |---|---|---|---| | Brewed green tea, 1 to 3 cups/day | ~50 to 100 mg/day | Low | No action needed | | Single standardized capsule, 400 mg EGCG | 400 mg/day | Moderate | Discuss with prescriber; baseline LFTs | | Two capsules daily or weight-loss stack | 800 to 1,600 mg/day | High | Discontinue extract; inform prescriber | | Pre-workout with 3 servings/day | 1,500 to 3,000 mg/day | Very High | Stop immediately; check liver enzymes |